Lupin gets USFDA nod to market generic skin treatment medication

Fluocinolone Acetonide Topical Oil is used for the treatment of skin issues

100
USFDA Approval
USFDA Approval

Last Updated on October 2, 2024 by The Health Master

New Delhi: Lupin said its American subsidiary has received approval from the US Food and Drug Administration (USFDA) to market a generic product used for the treatment of skin issues.

New Jersey-based Novel Laboratories Inc. has received approval from the USFDA for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.

The product is the generic version of Hill Dermaceuticals Inc.’s Derma-Smoothe/FS Topical Oil.

Lupin said the product will be manufactured at its Somerset facility in the US.

As per the IQVIA MAT March 2023 data, Fluocinolone Acetonide Topical Oil had estimated annual sales of USD 9 million in the US.

Lupin shares were trading 0.67 percent lower at Rs 981.65 apiece on the BSE.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news